M

Researcher Profile

Marcel Nijland

0000-0002-2740-2873

3

Publications

32

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article Blood Nov 03, 2025

primary Phase 3 results from the epcore FL-1 trial of epcoritamab with rituximab and lenalidomide (R2) versus R2 for relapsed or refractory follicular lymphoma

Lorenzo Falchi · Marcel Nijland · Huiqiang Huang · Kim Linton +24 more

10.1182/blood-2025-466 2 citations

Journal Article The Lancet Haematology May 01, 2023

European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

Cristina Nanni · Carsten Kobe · Bettina Baessler · Christian Baues +26 more

10.1016/s2352-3026(23)00030-3 20 citations

Open Access Journal Article European Journal of Cancer Nov 01, 2022

Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis

Frederik O. Meeuwes · Mirian Brink · Marjolein W.M. van der Poel · Marie José Kersten +13 more

10.1016/j.ejca.2022.09.008 10 citations

Publication Timeline

2025

1

2023

1

2022

1

Frequent Co-Authors

Shane Gangatharan

Theodoros Vassilakopoulos

Pim G.N.J. Mutsaers

Françoise Kraeber-Bodéré

Martin Hutchings

Patty M. Jansen